We are live on
!
Find out more
Calamos Advisors Portfolio holdings
AUM
$28.2B
1-Year Est. Return
21.78%
This Fund
S&P 500
This Quarter
Est. Return
+2.73%
1 Year Est. Return
+21.78%
3 Year Est. Return
+69.57%
5 Year Est. Return
+92%
10 Year Est. Return
+282.63%
AUM
$13.5B
AUM Growth
+$829M
(+6.5%)
Cap. Flow
-$2.52B
Cap. Flow
% of AUM
-18.66%
Top 10 Holdings %
Top 10 Hldgs %
16.93%
Holding
671
New
60
Increased
214
Reduced
141
Closed
65
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BDXA
Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6
BDXA
|
+$58.5M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$31.2M |
| 3 |
Apple
AAPL
|
+$24.7M |
| 4 |
NCR Voyix
VYX
|
+$23.5M |
| 5 |
Amgen
AMGN
|
+$22.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$55.5M |
| 2 |
AMT.PRA
American Tower Corporation
AMT.PRA
|
+$53.6M |
| 3 |
Meta Platforms (Facebook)
META
|
+$48.2M |
| 4 |
EXCU
Exelon Corporation
EXCU
|
+$46.4M |
| 5 |
Costco
COST
|
+$37.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 11% |
| 2 | Technology | 9.33% |
| 3 | Healthcare | 8.36% |
| 4 | Industrials | 6.68% |
| 5 | Communication Services | 6.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
NetEase
NTES
$76.5B
| $3.94M | 0.03% |
65,550
-64,900
| -50% | -$3.72M |
|
302
PPG Industries
PPG
$25.9B
| $3.89M | 0.03% |
35,389
+938
| +3% | +$101K |
|
303
McKesson
MCK
$98.5B
| $3.88M | 0.03% |
+23,593
| New | +$3.58M |
|
304
CALL
Intel
INTC
$466B
| $3.86M | 0.03% |
+114,500
| New | +$4.1M |
|
305
Regions Financial
RF
$26.3B
| $3.86M | 0.03% |
263,718
+59,327
| +29% | +$835K |
|
|
VAR
306
DELISTED
Varian Medical Systems, Inc.
VAR
| $3.85M | 0.03% |
37,295
+7,297
| +24% | +$703K |
|
307
TransDigm Group
TDG
$69.2B
| $3.83M | 0.03% |
14,231
+2,779
| +24% | +$705K |
|
308
Church & Dwight Co
CHD
$23.1B
| $3.75M | 0.03% |
+72,261
| New | +$3.69M |
|
309
FirstEnergy
FE
$28.9B
| $3.72M | 0.03% |
127,695
+77,623
| +155% | +$2.31M |
|
310
Devon Energy
DVN
$51.9B
| $3.71M | 0.03% |
115,888
+2,448
| +2% | +$89.5K |
|
311
Travelers Companies
TRV
$80.8B
| $3.71M | 0.03% |
29,279
+708
| +2% | +$87.1K |
|
312
General Mills
GIS
$19.2B
| $3.68M | 0.03% |
66,450
+1,761
| +3% | +$100K |
|
313
Valero Energy
VLO
$89.8B
| $3.68M | 0.03% |
54,565
+1,344
| +3% | +$87.2K |
|
314
Idexx Laboratories
IDXX
$42.9B
| $3.67M | 0.03% |
22,763
+615
| +3% | +$99.9K |
|
315
Macerich
MAC
$7.32B
| $3.64M | 0.03% |
62,750
+40,106
| +177% | +$2.43M |
|
316
Zimmer Biomet
ZBH
$17.7B
| $3.64M | 0.03% |
29,199
-88,365
| -75% | -$10.5M |
|
317
Vertex Pharmaceuticals
VRTX
$121B
| $3.63M | 0.03% |
+28,207
| New | +$3.4M |
|
318
Prologis
PLD
$138B
| $3.62M | 0.03% |
61,641
-832
| -1% | -$46.3K |
|
319
AES
AES
$10.6B
| $3.61M | 0.03% |
324,553
+121,185
| +60% | +$1.39M |
|
|
CERN
320
DELISTED
Cerner Corp
CERN
| $3.59M | 0.03% |
54,003
+1,431
| +3% | +$91.4K |
|
321
Ulta Beauty
ULTA
$20.4B
| $3.56M | 0.03% |
12,390
+335
| +3% | +$97.8K |
|
|
FITB
322
Fifth Third Bancorp
FITB
$52B
| $3.52M | 0.03% |
135,667
-224,877
| -62% | -$5.56M |
|
|
STI
323
DELISTED
SunTrust Banks, Inc.
STI
| $3.5M | 0.03% |
61,755
+1,673
| +3% | +$93K |
|
324
Darden Restaurants
DRI
$22.5B
| $3.48M | 0.03% |
38,458
+7,241
| +23% | +$633K |
|
325
Hartford Financial Services
HIG
$38.5B
| $3.44M | 0.03% |
65,450
-4,225
| -6% | -$209K |
|
Similar funds
PCH
N
TWC
FDCDDQ
NA
Calamos Advisors's Q2 2017 Portfolio in Review
As of Q2 2017, Calamos Advisors held 671 positions worth $13.5B, up 6.5% from $12.7B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Calamos Advisors withdrew a net $2.52B in Q2 2017, closing 65 positions and reducing 141 holdings. Its most notable exit was American Tower Corporation, an estimated $53.6M position sold in full.
By sector, the portfolio is most concentrated in Financials at 11% of assets, down from 11% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Calamos Advisors opened a new position in Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6 worth $59.5M.
- Calamos Advisors's largest Q2 2017 buy was Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6: 1,086,994 shares worth $59.5M.
- Calamos Advisors added most to Alexion Pharmaceuticals in Q2 2017, an estimated $31.2M increase.
- Calamos Advisors's biggest Q2 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $55.5M.
- Calamos Advisors fully exited American Tower Corporation in Q2 2017, selling an estimated $53.6M.
- Calamos Advisors's ten largest holdings make up 17% of its $13.5B portfolio in Q2 2017.
- Calamos Advisors opened 60 new positions and closed 65 in Q2 2017.
- Calamos Advisors's portfolio value rose 6.5% quarter-over-quarter to $13.5B.
Based on Calamos Advisors's 13F filing for Q2 2017, filed 9 Aug 2017.